Calidi Biotherapeutics, Inc.·4

Oct 15, 9:14 PM ET

Peoples George 4

4 · Calidi Biotherapeutics, Inc. · Filed Oct 15, 2024

Insider Transaction Report

Form 4
Period: 2024-09-20
Transactions
  • Award

    Non-Qualified Stock Options (right to buy)

    2024-09-20+20,21720,217 total
    Exercise: $1.09Exp: 2034-09-20Common stock (20,217 underlying)
Footnotes (1)
  • [F1]On October 11, 2024, pursuant to the issuer's 2023 Equity Incentive Plan, the reporting person was issued a non-qualified stock option to purchase 20,217 shares of common stock (the "Options") at an exercise price of $1.09, which is the closing price of the issuer's common stock on the grant date, September 20, 2024 (the "Grant Date"). The Options shall vest, and become exercisable, in 1/12th per month installments over one year commencing on the Grant Date.

Documents

1 file
  • 4
    ownership.xmlPrimary